Genvec Inc (GNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,840 | 3,958 | 4,150 | 4,972 | 4,074 |
| Marketable Securities | 3,501 | 7,825 | 11,105 | 13,223 | 16,873 |
| Receivables | 652 | 772 | 947 | 991 | 1,448 |
| TOTAL | $11,092 | $13,031 | $16,428 | $19,497 | $22,869 |
| Non-Current Assets | |||||
| PPE Net | 843 | 985 | 805 | 777 | 816 |
| Other Non-Current Assets | 253 | 225 | 197 | 171 | 150 |
| TOTAL | $1,096 | $1,210 | $1,002 | $948 | $966 |
| Total Assets | $12,188 | $14,241 | $17,430 | $20,445 | $23,835 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,129 | 1,355 | 1,500 | 1,575 | 1,610 |
| Accrued Expenses | 1,418 | 1,445 | 2,187 | 2,275 | 1,895 |
| TOTAL | $3,971 | $3,210 | $3,687 | $3,854 | $3,535 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,424 | 410 | N/A | 4 | 30 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,971 | $3,210 | $3,687 | $3,854 | $3,535 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,295 | 1,295 | 1,295 | 1,295 | 1,295 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -271,932 | -268,806 | -265,761 | -262,602 | -258,563 |
| Other shareholders' equity | -8 | -15 | -27 | -9 | -27 |
| TOTAL | $8,217 | $11,031 | $13,743 | $16,591 | $20,300 |
| Total Liabilities And Equity | $12,188 | $14,241 | $17,430 | $20,445 | $23,835 |